ATE279930T1 - Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthrose - Google Patents
Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthroseInfo
- Publication number
- ATE279930T1 ATE279930T1 AT98907760T AT98907760T ATE279930T1 AT E279930 T1 ATE279930 T1 AT E279930T1 AT 98907760 T AT98907760 T AT 98907760T AT 98907760 T AT98907760 T AT 98907760T AT E279930 T1 ATE279930 T1 AT E279930T1
- Authority
- AT
- Austria
- Prior art keywords
- metal bicarbonate
- alkali metal
- osteoarthrosis
- treatment
- aqueous alkaline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO5677A AUPO567797A0 (en) | 1997-03-17 | 1997-03-17 | An aqueous metal bicarbonate solution and method of use |
AUPP0608A AUPP060897A0 (en) | 1997-11-28 | 1997-11-28 | An aqueous metal bicarbonate solution and method of use |
PCT/AU1998/000168 WO1998041218A1 (en) | 1997-03-17 | 1998-03-16 | An aqueous metal bicarbonate solution and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE279930T1 true ATE279930T1 (de) | 2004-11-15 |
Family
ID=25645376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98907760T ATE279930T1 (de) | 1997-03-17 | 1998-03-16 | Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthrose |
Country Status (7)
Country | Link |
---|---|
US (5) | US6048553A (de) |
EP (2) | EP1447086A1 (de) |
AT (1) | ATE279930T1 (de) |
CA (1) | CA2283326C (de) |
DE (1) | DE69827143D1 (de) |
NZ (1) | NZ500170A (de) |
WO (1) | WO1998041218A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2116257T3 (da) * | 2000-08-09 | 2013-02-04 | Alk Abello As | Parenterale vaccineformuleringer og anvendelser deraf |
US7858602B2 (en) | 2000-10-16 | 2010-12-28 | Rodriguez Victorio C | Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells |
US20030228374A1 (en) * | 2002-06-07 | 2003-12-11 | Pesacreta Thomas C. | Topical treatment for skin irritation |
GB0306073D0 (en) * | 2003-03-18 | 2003-04-23 | Meffert Uwe | Potable mineral water and methods for the production thereof |
WO2004097426A2 (en) * | 2003-05-01 | 2004-11-11 | Kudos Pharmaceuticals Limited | Methods and means for the treatment of disorders associated with cellular senescence |
WO2006008242A1 (en) * | 2004-07-19 | 2006-01-26 | Shell Internationale Research Maatschappij B.V. | Process for producing caco3 or mgco3 |
WO2006081014A2 (en) | 2004-12-23 | 2006-08-03 | Nonomura Arthur M | Cytochrome p450 enzyme complexes and methods of treatment using the same |
US7321798B2 (en) * | 2005-03-31 | 2008-01-22 | Medtronic, Inc. | Trans-septal/trans-myocardial ventricular pacing lead |
WO2007055044A1 (ja) * | 2005-11-08 | 2007-05-18 | Ajinomoto Co., Inc. | 麻酔覚醒促進剤 |
EP1992339A1 (de) * | 2007-05-18 | 2008-11-19 | Saeed Sarkar | Verwendung eines Magnesiumisotops zur Behandlung von Hypoxie und Medikament dazu |
US7879996B2 (en) | 2007-05-18 | 2011-02-01 | Saeed Sarkar | Water soluble compounds |
KR100926027B1 (ko) | 2007-12-10 | 2009-11-11 | 조성제 | 탄산수의 제조방법 및 이를 이용하여 제조된 탄산수 |
US8162917B2 (en) * | 2008-05-21 | 2012-04-24 | Onpharma, Inc. | Methods and apparatus for buffering anesthetics |
US20110005958A1 (en) * | 2009-07-09 | 2011-01-13 | Onpharma, Inc. | METHODS AND SYSTEMS FOR ADJUSTING THE pH OF MEDICAL BUFFERING SOLUTIONS |
WO2010039205A2 (en) * | 2008-09-30 | 2010-04-08 | Paul Michael Pedersen | Appliance for the alkalizing of water |
US8303566B2 (en) | 2009-07-09 | 2012-11-06 | Onpharma, Inc. | Methods and apparatus for buffering parenteral solutions |
AU2010242527A1 (en) * | 2009-04-30 | 2011-12-01 | Unique Global Possibilities Medical Pty Limited | Bicarbonate solution for bioavailable magnesium and uses thereof |
US8585963B2 (en) | 2009-07-09 | 2013-11-19 | Onpharma, Inc. | Methods and devices for sterilizing and holding buffering solution cartridges |
PL2454012T3 (pl) | 2009-07-09 | 2018-04-30 | Onpharma, Inc. | Sposób i urządzenie do sterylizacji i przechowywania wkładów z roztworem buforującym |
IL201568A (en) | 2009-10-15 | 2014-05-28 | Eitan Dafny | Process and facility for creating drinking water enriched with magnesium |
EP2371372A1 (de) * | 2010-04-01 | 2011-10-05 | Anrold Forbes | Verfahren zur Unterstützung der Appetitunterdrückung mittels Alkalimetallen |
DE102010039489A1 (de) * | 2010-08-18 | 2012-02-23 | Fresenius Medical Care Deutschland Gmbh | Konzentrat |
MX357515B (es) | 2010-11-15 | 2018-07-12 | Onpharma Inc | Aparato y métodos para secuestrar fluidos expulsados durante la transferencia de fluido. |
US20120279179A1 (en) * | 2011-04-26 | 2012-11-08 | Onpharma, Inc. | Methods and apparatuses for manufacturing a plurality of cartridges of medical buffering solution with a common ph |
DE102012002316A1 (de) * | 2012-02-06 | 2013-08-08 | Samson Aktiengesellschaft | Stellventil zum Einstellen einer Prozessfluidströmung in einer prozesstechnischen Anlage |
US20140158639A1 (en) * | 2012-12-12 | 2014-06-12 | Water Stabilization And Revitalization | Water stabilization and revitalization |
CA2978680A1 (en) | 2015-03-04 | 2016-09-09 | Arnold Forbes | Compositions and methods for treating drug addiction |
JP6579948B2 (ja) * | 2015-12-24 | 2019-09-25 | 株式会社日立ハイテクノロジーズ | 生体ポリマを分析するための測定試薬及び分析デバイス |
BE1024584B1 (fr) | 2017-07-28 | 2018-04-11 | Flamingo Holding Sa | Methode et appareil domestique de production d’eau minerale a partir d’une eau de ville |
EP3813555A4 (de) * | 2018-06-29 | 2022-03-30 | Tets, Viktor, Veniaminovich | Zusammensetzungen zur modulierung der darmflora |
US11925703B1 (en) | 2022-07-29 | 2024-03-12 | Xellia Pharmaceuticals Aps | Liquid composition comprising glucose |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3878664A (en) * | 1972-11-27 | 1975-04-22 | Cybersol | Process for producing a therapeutic composition |
CA1017249A (en) * | 1973-12-19 | 1977-09-13 | Chemo Drug Company | Injectable electrolyte solutions |
US4588744A (en) * | 1978-09-19 | 1986-05-13 | Mchugh John E | Method of forming an aqueous solution of 3-3-Bis(p-hydroxyphenyl)-phthalide |
US4489535A (en) * | 1980-10-02 | 1984-12-25 | Veltman Preston Leonard | Materials and method for preparing dialysis solutions containing bicarbonate ions |
US4548817A (en) * | 1984-01-20 | 1985-10-22 | Webb-Waring Lung Institute | Composition and method for treating mammalian acidosis |
US4663289A (en) * | 1984-06-22 | 1987-05-05 | Veech Richard L | Electrolyte solutions and in vitro use thereof |
US5409904A (en) * | 1984-11-13 | 1995-04-25 | Alcon Laboratories, Inc. | Hyaluronic acid compositions and methods |
FR2625679B1 (fr) * | 1988-01-08 | 1990-02-09 | Commin Alix | Preparation aqueuse a base de sels mineraux et d'acide acetique pour la prevention et le traitement des maladies virales |
ES2056497T3 (es) * | 1990-01-12 | 1994-10-01 | Nephro Medica Pharma | Solucion para infusion y dialisis que contiene bicarbonato y calcio. |
DD297062A5 (de) * | 1990-08-23 | 1992-01-02 | Tks Optimum Gmbh,Dd | Verfahren zur herstellung eines neuartigen topischen dermatikums mit antientzuendlicher wirkung |
DE4125819A1 (de) * | 1991-08-03 | 1993-02-04 | Rolf Prof Dr Med Zander | Waessrige loesung und deren verwendung |
EP0546728A3 (en) * | 1991-12-13 | 1993-09-08 | Alcon Laboratories Inc | Physiological tear compositions and methods for their preparation |
US5523316A (en) * | 1994-06-23 | 1996-06-04 | Alcon Laboratories, Inc. | Intraocular irrigating solution containing agent for controlling IOP |
US5498426A (en) * | 1994-10-03 | 1996-03-12 | The Procter & Gamble Company | Liquid antacid compositions |
WO2003086973A1 (en) * | 2002-04-05 | 2003-10-23 | Bertshell Pty Ltd | Process and apparatus for use in preparing an aqueous magnesium bicarbonate solution |
-
1998
- 1998-03-13 US US09/041,787 patent/US6048553A/en not_active Expired - Lifetime
- 1998-03-16 NZ NZ500170A patent/NZ500170A/en not_active IP Right Cessation
- 1998-03-16 AT AT98907760T patent/ATE279930T1/de not_active IP Right Cessation
- 1998-03-16 WO PCT/AU1998/000168 patent/WO1998041218A1/en active IP Right Grant
- 1998-03-16 CA CA002283326A patent/CA2283326C/en not_active Expired - Fee Related
- 1998-03-16 EP EP04004350A patent/EP1447086A1/de not_active Withdrawn
- 1998-03-16 DE DE69827143T patent/DE69827143D1/de not_active Expired - Lifetime
- 1998-03-16 EP EP98907760A patent/EP1005351B1/de not_active Expired - Lifetime
-
1999
- 1999-10-22 US US09/422,645 patent/US6328997B1/en not_active Expired - Fee Related
-
2001
- 2001-09-26 US US09/962,163 patent/US6544561B2/en not_active Expired - Fee Related
-
2003
- 2003-01-21 US US10/347,284 patent/US20030180386A1/en not_active Abandoned
-
2004
- 2004-03-12 US US10/798,451 patent/US20040175437A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1005351A1 (de) | 2000-06-07 |
CA2283326A1 (en) | 1998-09-24 |
US6544561B2 (en) | 2003-04-08 |
US6048553A (en) | 2000-04-11 |
DE69827143D1 (de) | 2004-11-25 |
WO1998041218A1 (en) | 1998-09-24 |
US6328997B1 (en) | 2001-12-11 |
NZ500170A (en) | 2001-11-30 |
EP1005351A4 (de) | 2000-09-27 |
EP1447086A1 (de) | 2004-08-18 |
US20030180386A1 (en) | 2003-09-25 |
US20040175437A1 (en) | 2004-09-09 |
US20020064566A1 (en) | 2002-05-30 |
CA2283326C (en) | 2008-05-13 |
EP1005351B1 (de) | 2004-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE279930T1 (de) | Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthrose | |
EP0786458A3 (de) | Derivate und analoge der 2-Deoxy-2,3-didehydro-N-acetyl-Neuraminsäure und ihre Verwendung als antivirale Agentien | |
FI875308A (fi) | Foerfarande i tvao steg foer att hela ett saor smaertfritt och ett vattenhaltigt medium och en salva foer lokal anvaendning vid foerfarandet. | |
AR000960A1 (es) | Procedimiento para producir un medicamento inhalable para el tratamiento o prevencion de restenosis arterial. | |
AU4722785A (en) | Initiating reperfusion treatment when heart attack symptoms are present | |
DE69727956D1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
ATE209922T1 (de) | Pharmazeutische zusammensetzung von stickstoffmonoxid | |
KR0141913B1 (en) | Anti-virus agents | |
FI940659A0 (fi) | Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia | |
JPH035427A (ja) | 薬剤組成物 | |
HUT72670A (en) | Containing galanthamine pharmaceutical composition for treating nicotine dependence | |
MY109531A (en) | Effervescent antacid | |
DE59911256D1 (de) | Verfahren zur Herstellung von wässrigen Natriummethioninat-Lösungen und Verwendung dieser Lösungen zur Herstellung eines Granulats | |
TW337997B (en) | Pharmaceutical preparation containing plasminogen activators | |
EP0848948A4 (de) | Lang wirksames mittel zur rektalen verabreichung | |
BR9205700A (pt) | Aperfeiçoamento em um processo para purificar e preservar fator IX derivado de plasma do sangue humano ou outra fonte, processos para a preparação de uma composição terapêutica, e para estabilizar fator IX, solução aquosa de fator IX parcialmente purificado, composição terapêutica e processo para tratar doença de christmas. | |
HU901617D0 (en) | Herbicide compositions containing {[(1,3,5-triazin-2-yl)-amino-carbonyl]-amino-sulfonyl}-benzoic acid esters and process for the preparation of the active ingredients | |
LV5660A3 (lv) | Panemiens pretvirusu lidzekla iegusanai | |
SI0875248T1 (en) | Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid | |
DK492989A (da) | Aminopyrrolidinon, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling deraf | |
KR920014474A (ko) | 담석 붕괴용 제제 | |
GR3036481T3 (en) | Medicament containing delta-aminolevulinic acid | |
KR910000795A (ko) | S-술폰화 칼시토닌 유도체, 그 제조방법, 약제학적 조성물 및 치료방법 | |
JPS5762218A (en) | Ophthalmic solution | |
FI915612A0 (fi) | Komposition foer behandling av vaexter och dess anvaendningar. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |